本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corcept医疗

121.19
0.0000
盘后:121.190.00000.00%19:32 EDT
成交量:49.77万
成交额:6,026.58万
市值:131.00亿
市盈率:267.14
高:122.09
开:121.24
低:119.28
收:121.19
52周最高:126.38
52周最低:28.66
股本:1.08亿
流通股本:9,644.01万
量比:0.70
换手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):0.4537
每股收益(LYR):0.8200
净资产收益率:8.23%
总资产收益率:0.47%
市净率:18.56
市盈率(LYR):147.79

数据加载中...

2024/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/01

重要事件披露

Form 8-K - Current report
2024/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities